Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development, manufacturing and commercialization of novel therapeutics for human health care7.02M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States7.02M100.00%